Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

被引:4088
作者
Kitada, T
Asakawa, S
Hattori, N
Matsumine, H
Yamamura, Y
Minoshima, S
Yokochi, M
Mizuno, Y
Shimizu, N
机构
[1] Keio Univ, Sch Med, Dept Biol Mol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1130033, Japan
[3] Hiroshima Univ, Sch Med, Dept Hlth Sci, Minami Ku, Hiroshima 7340037, Japan
[4] Tokyo Metropolitan Ebara Hosp, Dept Neurol, Ota Ku, Tokyo 1450065, Japan
关键词
D O I
10.1038/33416
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Parkinson's disease is a common neurodegenerative disease with complex clinical features(1). Autosomal recessive juvenile parkinsonism (AR-JP)(2,3) maps to the long arm of chromosome 6 (6q25.2-q27) and is linked strongly to the markers D6S305 and D6S253 (ref. 4); the former is deleted in one Japanese AR-JP patient(5). By positional cloning within this microdeletion, we have now isolated a complementary DNA clone of 2,960 base pairs with a 1,395-base-pair open reading frame, encoding a protein of 465 amino acids with moderate similarity to ubiquitin at the amino terminus and a RING-finger motif at the carboxy terminus, The gene spans more than 500 kilobases and has 12 exons, five of which (exons 3-7) are deleted in the patient, Four other AR-JP patients from three unrelated families have a deletion affecting exon 4 alone. A 4.5-kilobase transcript that is expressed in many human tissues but is abundant in the brain, including the substantia nigra, is shorter in brain tissue from one of the groups of exon-4-deleted patients. Mutations in the newly identified gene appear to be responsible for the pathogenesis of AR-JP, and we have therefore named the protein product 'Parkin'.
引用
收藏
页码:605 / 608
页数:4
相关论文
共 27 条
[1]   THE PHD FINGER - IMPLICATIONS FOR CHROMATIN-MEDIATED TRANSCRIPTIONAL REGULATION [J].
AASLAND, R ;
GIBSON, TJ ;
STEWART, AF .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (02) :56-59
[2]   Human BAC library: Construction and rapid screening [J].
Asakawa, S ;
Abe, I ;
Kudoh, Y ;
Kishi, N ;
Wang, YM ;
Kubota, R ;
Kudoh, J ;
Kawasaki, K ;
Minoshima, S ;
Shimizu, N .
GENE, 1997, 191 (01) :69-79
[3]   ETIOLOGY OF PARKINSONS-DISEASE [J].
CALNE, DB ;
LANGSTON, JW .
LANCET, 1983, 2 (8365) :1457-1459
[4]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[5]   THE TAILS OF UBIQUITIN PRECURSORS ARE RIBOSOMAL-PROTEINS WHOSE FUSION TO UBIQUITIN FACILITATES RIBOSOME BIOGENESIS [J].
FINLEY, D ;
BARTEL, B ;
VARSHAVSKY, A .
NATURE, 1989, 338 (6214) :394-401
[6]  
FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325
[7]  
GALLOWAY PG, 1992, AM J PATHOL, V140, P809
[8]   AMYLOID BETA-PROTEIN INHIBITS UBIQUITIN-DEPENDENT PROTEIN-DEGRADATION IN-VITRO [J].
GREGORI, L ;
FUCHS, C ;
FIGUEIREDOPEREIRA, ME ;
VANNOSTRAND, WE ;
GOLDGABER, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19702-19708
[9]  
GREGORI L, 1990, J BIOL CHEM, V265, P8354
[10]   UBIQUITIN, PROTEASOMES, AND THE REGULATION OF INTRACELLULAR PROTEIN-DEGRADATION [J].
HOCHSTRASSER, M .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (02) :215-223